Elevated D-Dimer and Hypoalbuminemia as Predictors of Early Mortality in Cancer-Associated Pulmonary Embolism
Oncology · 2025
DOI: 10.1159/000550191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2025. Verfasst von Berrin Zinnet Eraslan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, University of Health Sciences, Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey, berzinbalta@yahoo.com. Hauptthemen laut MEDLINE: Pulmonary Embolism, Fibrin Fibrinogen Degradation Products, Neoplasms, Hypoalbuminemia. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
Patients with active cancer have a 4- to 7-fold increased risk of venous thromboembolism (VTE) compared with the general population and are known to have higher mortality rates. Pulmonary embolism (PE), as a common manifestation of VTE, represents a significant contributor to early mortality in this population. This study aimed to evaluate clinical and biochemical factors associated with short-term mortality in hospitalized patients with cancer diagnosed with acute PE.
Methods
This retrospective study included 84 patients with active malignancy and radiologically confirmed acute PE hospitalized at a tertiary care center. Demographic, clinical, and laboratory parameters were collected. The primary outcome was all-cause 1-month mortality. Univariate and multivariate logistic regression analyses were performed to identify independent predictors. Receiver operating characteristic curve analysis was used to assess the prognostic performance of D-dimer.
Results
Among hospitalized patients with cancer with acute PE, the 30-day mortality rate was 26.2%. Non-survivors had higher D-dimer levels and lower serum albumin levels. D-dimer levels did not differ between patients with and without metastasis (p = 0.223). In the multivariate model adjusted for metastatic status, log-transformed D-dimer remained an independent predictor of 30-day mortality (OR: 37.19; p = 0.014), whereas albumin showed a borderline association (OR: 0.30; p = 0.052). A D-dimer cutoff of 4.186 ng/mL predicted mortality with 75% sensitivity and 70% specificity (AUC: 0.76). Combining D-dimer and albumin further increased predictive accuracy (AUC: 0.83).
Conclusion
D-dimer independently predicted short-term mortality in hospitalized patients with cancer with acute PE even after adjustment for metastatic status; albumin demonstrated only a borderline association. These routinely available biomarkers may support early risk assessment but should be interpreted cautiously in the context of other clinical factors. Prospective studies are needed to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Diseases, University of Health Sciences, Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey, berzinbalta@yahoo.com.
- Department of Pulmonary Diseases, University of Health Sciences, Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey.
Zitieren
APA
Eraslan, B. Z., Bayrak, B., Kıral, N., & Cömert, S. (2025). Elevated D-Dimer and Hypoalbuminemia as Predictors of Early Mortality in Cancer-Associated Pulmonary Embolism. Oncology. https://doi.org/10.1159/000550191
Vancouver
Eraslan BZ, Bayrak B, Kıral N, Cömert S. Elevated D-Dimer and Hypoalbuminemia as Predictors of Early Mortality in Cancer-Associated Pulmonary Embolism. Oncology. 2025. doi:10.1159/000550191
BibTeX
@article{Eraslan2025,
author = {Eraslan, Berrin Zinnet and Bayrak, Burcu and Kıral, Nesrin and Cömert, Sevda},
title = {Elevated D-Dimer and Hypoalbuminemia as Predictors of Early Mortality in Cancer-Associated Pulmonary Embolism},
journal = {Oncology},
year = {2025},
doi = {10.1159/000550191}
}
EUVIMED